-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on Anixa Biosciences, Maintains $10 Price Target

Benzinga·02/04/2026 13:03:20
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $10 price target.